Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 2Thoracic 1Head & Neck 1Gynecologic 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Testicular Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Renal Insufficiency 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Neoplasms, Unknown Primary 1Neoplasm Metastasis 1Melanoma 1Lung Neoplasms 1Liver Failure 1Head and Neck Neoplasms 1Esophageal Neoplasms 1Endometrial Neoplasms 1Carcinoma, Transitional Cell 1Breast Neoplasms 1

Interventions

Filgrastim 3Carboplatin 3sargramostim 2Trastuzumab 2Taxes 2Peripheral Blood Stem Cell Transplantation 2Magnetic Resonance Spectroscopy 2Fluorodeoxyglucose F18 2FAPI-46 2veliparib 1tremelimumab 1trastuzumab deruxtecan 1tipifarnib 1poly ICLC 1etoposide phosphate 1erythromycin propionate-N-acetylcysteinate 1entinostat 1durvalumab 1cc-486 1brodalumab 1aldesleukin 1Topotecan 1Thiotepa 1Temozolomide 1Quality of Life 1Psychology, Positive 1Polymerase Chain Reaction 1Patient Reported Outcome Measures 1Paclitaxel 1Oxaliplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Testicular Neoplasms × veliparib × Head & Neck × Clear all
NCT01366144 2026-04-13

Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction

National Cancer Institute (NCI)

Phase 1 Active not recruiting
94 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Breast Neoplasms, Carcinoma, Transitional Cell, Esophageal Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Neoplasms, Unknown Primary, Ovarian Neoplasms, Testicular Neoplasms, Endometrial Neoplasms, Liver Failure, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡